Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes
Abstract Understanding the association between compliance to the Chronic Kidney Disease (CKD) guidelines in real-world clinical settings and renal outcomes remains a critical gap in knowledge. A comprehensive analysis was conducted using data from a national, multicenter CKD registry. This study inc...
Main Authors: | Zannatun Nyma, Kaori Kitaoka, Yuichiro Yano, Hiroshi Kanegae, Nomin Bayaraa, Seiji Kishi, Hajime Nagasu, Toshiaki Nakano, Jun Wada, Shoichi Maruyama, Naoki Nakagawa, Kouichi Tamura, Takashi Yokoo, Motoko Yanagita, Ichiei Narita, Kunihiro Yamagata, Takashi Wada, Kazuhiko Tsuruya, Naoki Nakashima, Yoshitaka Isaka, Masaomi Nangaku, Naoki Kashihara, Hirokazu Okada, J-CKD-DB study collaborative |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-05-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-62152-6 |
Similar Items
-
Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)
by: Sho Shimamoto, et al.
Published: (2024-11-01) -
Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).
by: Tadashi Sofue, et al.
Published: (2020-01-01) -
Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex
by: Kaori Kitaoka, et al.
Published: (2024-06-01) -
Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease
by: Shinji Kume, et al.
Published: (2018-07-01) -
Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS‐3150) and sodium–glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies
by: Kenichi Shikata, et al.
Published: (2022-07-01)